The topic covered by this document includes the monitoring of CIEDs with a description of the technology, indications for use, personnel involved in monitoring and the frequency and types of monitoring events. Also covered are issues in regard to data management, regulatory environments, reimbursement and ethical considerations in respect to device inactivation.
May 14, 2010 - This document was developed in collaboration with and endorsed by the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM); the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), and the Hospice and Palliative Nurses Association (HPNA). It focuses on patients nearing the end of life and addresses patients who have made a decision for CIED deactivation at other times, as well as the rights and responsibilities of clinicians (and others, such as industry-employed allied professionals) who may not wish to perform deactivation.
May 13, 2015 - The Heart Rhythm Society, in partnership with the National Stroke Association, developed an survey initiative that sought characterize the impact of stroke on AF patients and their caregivers; gaps in knowledge and perspective among physicians and patients; and barriers to effective communication and optimal anticoagulation use.
November 18, 2014 - The Heart Rhythm Society convened a research symposium on December 9–10, 2013, in Washington, DC, that focused on the prevention of atrial fibrillation (AF) as well as AF-related stroke and morbidity.Attendees sought to summarize advances in understanding AF since a 2008 National Institutes of Health(NIH) conference on this topic and to identify continued knowledge gaps and current research priorities. This resultant whitepaper was developed in collaboration with and endorsed by the European Heart Rhythm Association (EHRA) and the Canadian Heart Rhythm Society (CHRS). It summarizes the deliberations of the attendees in an effort to accelerate progress toward preventing AF and its consequences.
September 29, 2014 - This document is a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography.The purpose is to establish and evaluate Appropriate Use Criteria (AUC) for the initial use of outpatient pediatric echocardiography.
June 1, 2016 - This consensus statement provides up-to-date clinical practice guidelines for the use of catheter ablation in children 0–18 years of age with any arrhythmia, and in all patients with congenital heart disease.
April 26, 2011 - On October 18, 2010, HRS convened the Relationships with Industry Task Force to consider whether it should continue to collaborate with industry, why collaboration may be important, and to set parameters around industry collaboration. The Task Force concluded that collaboration with industry on research and innovation is required to achieve HRS’s mission. Nevertheless, because the potential for actual or perceived bias or conflict of interest does exist, it is necessary to establish strict ethical standards to protect the credibility of HRS and its members.
August 15, 2016 - IHE is an initiative undertaken by healthcare professionals and industry to facilitate and strengthen the sharing of clinical data among health information technology (IT) systems. Systems developed in accordance with IHE communicate with one another more readily and completely, are easier to implement, and enable care providers to use information more effectively.
July 2016 - Ventricular cardiomyopathies have been well classified; however, a definition and detailed analysis of ‘atrial cardiomyopathy’ is lacking from the literature. The purpose of the present consensus report was to define atrial cardiomyopathy, to review the relevant literature, and to consider the impact of atrial cardiomyopathies on arrhythmia management and stroke.